The misuse of these and other such drugs should serve as a wake-up call. These medications, meant to treat legitimate medical conditions, like epilepsy and neuropathic pain, are being treated as ...

Upsher-Smith is launching Kymbee (deflazacort) tablets. The branded generic medication is indicated for the treatment of ...

Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today announced it will participate in the American Epilepsy Society (AES) Annual Meeting December 5-9, 2025 in Atlanta. The ...

(GLOBE NEWSWIRE) -- (Nasdaq: SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ST-503, an investigational ...

Crawford and husband Rande Gerber's eldest detailed his regimen of blood pressure medications, opiates, benzodiazepines, ...

Biocodex, a global pharmaceutical company and long-time pioneer in the treatment of rare pediatric diseases, will present 12 studies at the upcoming AES 2025 Annual Meeting in Atlanta, Georgia, ...

Gabapentin is commonly prescribed for nerve pain, seizures, and restless legs syndrome, but it also carries certain risks.

To some extent, pharmacy closures reflect changes in purchasing patterns, as more people turn toward mail-order prescriptions ...

Many individuals struggle with low vitamin D levels despite regular supplementation due to factors like poor absorption, ...

The herb linked to reduced inflammation, lower anxiety, and reduced blood sugar - One of the world’s oldest herbs, use of ...

Gabapentin is commonly prescribed for nerve pain, epilepsy and diabetes-related pain, but NHS guidance warns it sometimes ...

Neuropathic Pain Market Size To Surpass $15.37 Billion By 2033, Driven By Surging Prevalence Of Diabetes, Cancer Cases & Advances In Non-Opioid Therapies SNS Insider. SNS Insider Highlights U.S.